banner

Latest News

Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. FDA Director as Vice Preside

From Business Wire: Rocket Pharmaceuticals Appoints Gayatri R. Rao, M.D., J.D., Former U.S. FDA Director of the Office of Orphan Products Development, as Vice President, Regulatory Policy and Patient AdvocacyRocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced the appointment of Gayatri R. Rao, M.D., J.D., as Vic...

Read More

Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems

From Aspect Biosystems: Genome BC Invests $1 million in Funding to Top Canadian 3D Bioprinting Company Aspect Biosystems   Vancouver, Canada — Genome BC is pleased to announce $1 million in funding to Aspect Biosystems (Aspect), a privately held biotechnology company focused on commercializing cutting-edge 3D bioprinting technologies. Aspect’s Lab-on-a-Printer™ 3D bioprinting pl...

Read More

The genomics-focused Illumina Accelerator backs five new companies including DermBiont

From TechCrunch: The genomics-focused Illumina Accelerator backs five new companies including DermBiont Illumina Accelerator, the genomics-focused startup accelerator backed by the publicly traded genetic sequencing pioneer Illumina  Corp., has picked five startups for its seventh accelerator class, the company announced.Wth technology addressing skin microbial therapeuti...

Read More

Wild Earth Introduces Cultured Clean Protein for $30B Pet Food Market

From PR Newswire: Wild Earth Introduces Cultured Clean Protein for $30B Pet Food Market BERKELEY, Calif., March 15, 2018 /PRNewswire/ -- Wild Earth, Inc., a biotech startup, announced today it is using cultured proteins to develop clean, high-quality pet foods for the $30 billion pet food market. Much like biotech companies creating cultured meats for human consumpt...

Read More

Synthetic Biology Firm Evonetix Raises $12.3M

A recent article on Evonetix: Synthetic biology firm Evonetix announced today that it has closed a $12.3 million financing round. The financing was co-led by Data Collective and Draper Esprit, and included Morningside Group along with existing investors Providence Investment Company, Cambridge Consultants, Rising Tide Fund, and Civilization Ventures. Evonetix was spun out of Ca...

Read More

Manus Bio Awarded Funding to Develop Novel Production Method for Artemisinin

A recent article about Manus BIo: Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received funding from the Bill & Melinda Gates Foundation for the development of a scalable and cost-effective production method for artemisinin, a key therapeutic for treating malaria. Manus Bio will use its ...

Read More

Johnson & Johnson Partner with Aspect Biosystems to Create 3D Printed Knee

From 3D Printing Industry: Johnson & Johnson Partner with Aspect Biosystems to Create 3D Printed Knee Having announced partnerships with Carbon and HP last year, pharmaceutical company Johnson & Johnson (J&J) have now outlined plans to integrate 3D printing into the development of medical devices. Johnson & Johnson have just revealed a new partnership with Aspect Biosystems and their ...

Read More

Alveo Closes $38 Million in Series A Financing to Create Accessible Diagnostics Devices

A recent article on Alveo Technologies $38M Series A: Alveo Technologies, Inc., ("Alveo" or "the Company") whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised by Maxim Merchant Capital, a division of Maxim Group LLC. The round was oversubscribed and included existing and ...

Read More

Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction

A recent article on Rocket Pharma merger and NASDAQ Listing: Rocket Pharmaceuticals, Ltd., a leading U.S.-based multi-platform gene therapy company addressing challenging rare diseases, today announced the completion of its merger with Inotek Pharmaceuticals Corporation Rocket utilizes a multi-platform development approach that leverages the well-established lentiviralvector (LVV)...

Read More